Gene Review:
HRVBgp1 - genome polyprotein
Human rhinovirus B14
Matthews,
Dragovich,
Webber,
Fuhrman,
Patick,
Zalman,
Hendrickson,
Love,
Prins,
Marakovits,
Zhou,
Tikhe,
Ford,
Meador,
Ferre,
Brown,
Binford,
Brothers,
DeLisle,
Worland,
Wang,
Johnson,
Cox,
Villarreal,
Loncharich,
Patick,
Brothers,
Maldonado,
Binford,
Maldonado,
Fuhrman,
Petersen,
Smith,
Zalman,
Burns-Naas,
Tran,
- Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein. Matthews, D.A., Smith, W.W., Ferre, R.A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J.E., Janson, C.A., McElroy, H.E., Gribskov, C.L. Cell (1994)
- Implications of the picornavirus capsid structure for polyprotein processing. Arnold, E., Luo, M., Vriend, G., Rossmann, M.G., Palmenberg, A.C., Parks, G.D., Nicklin, M.J., Wimmer, E. Proc. Natl. Acad. Sci. U.S.A. (1987)
- Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. Kong, J.S., Venkatraman, S., Furness, K., Nimkar, S., Shepherd, T.A., Wang, Q.M., Aubé, J., Hanzlik, R.P. J. Med. Chem. (1998)
- Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections. Wang, Q.M. Progress in drug research. Fortschritte der Arzneimittelforschung. Progrès des recherches pharmaceutiques. (2001)
- Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. Matthews, D.A., Dragovich, P.S., Webber, S.E., Fuhrman, S.A., Patick, A.K., Zalman, L.S., Hendrickson, T.F., Love, R.A., Prins, T.J., Marakovits, J.T., Zhou, R., Tikhe, J., Ford, C.E., Meador, J.W., Ferre, R.A., Brown, E.L., Binford, S.L., Brothers, M.A., DeLisle, D.M., Worland, S.T. Proc. Natl. Acad. Sci. U.S.A. (1999)
- Equine rhinovirus 1 is more closely related to foot-and-mouth disease virus than to other picornaviruses. Li, F., Browning, G.F., Studdert, M.J., Crabb, B.S. Proc. Natl. Acad. Sci. U.S.A. (1996)
- In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease. Patick, A.K., Brothers, M.A., Maldonado, F., Binford, S., Maldonado, O., Fuhrman, S., Petersen, A., Smith, G.J., Zalman, L.S., Burns-Naas, L.A., Tran, J.Q. Antimicrob. Agents Chemother. (2005)
- Sequences in the 5' non-coding region of human rhinovirus 14 RNA that affect in vitro translation. Alsaadi, S., Hassard, S., Stanway, G. J. Gen. Virol. (1989)
- The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. Jenkins, O., Booth, J.D., Minor, P.D., Almond, J.W. J. Gen. Virol. (1987)
- Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing. Murray, M.A., Janc, J.W., Venkatraman, S., Babé, L.M. Antivir. Chem. Chemother. (2001)
- The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Stanway, G., Hughes, P.J., Mountford, R.C., Minor, P.D., Almond, J.W. Nucleic Acids Res. (1984)
- Expression and purification of recombinant rhinovirus 14 3CD proteinase and its comparison to the 3C proteinase. Davis, G.J., Wang, Q.M., Cox, G.A., Johnson, R.B., Wakulchik, M., Dotson, C.A., Villarreal, E.C. Arch. Biochem. Biophys. (1997)
- The expression and purification of human rhinovirus protease 3C. Knott, J.A., Orr, D.C., Montgomery, D.S., Sullivan, C.A., Weston, A. Eur. J. Biochem. (1989)
- A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. Wang, Q.M., Johnson, R.B., Cox, G.A., Villarreal, E.C., Loncharich, R.J. Anal. Biochem. (1997)